Intimation for Re-Lodgement of Physical Share Transfer Requests
Vivimed Labs received a report on re-lodgement of physical share transfer requests as per SEBI guidelines. No requests were processed during October 2025.
The announcement is about a compliance update and does not have a significant impact on the company's operations or financials.
The announcement is a routine compliance update regarding share transfer requests.
* Vivimed Labs Limited announced the receipt of a report from their Registrar and Share Transfer Agent, Aarthi Consultants Pvt Ltd, regarding the re-lodgement of transfer requests for physical shares. * This action is in compliance with SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD/P/CIRl2025/97 dated July 02, 2025. * The report, dated November 04, 2025, indicates that during October 2025, no requests were received, processed, approved, or rejected for re-lodgement of physical shares. * The average time taken for processing such requests was also NIL.
What to do with a filing like this
Vivimed Labs Limited filed this with the NSE as a statutory disclosure, categorised under share transfer updates. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Vivimed Labs Limited. Read the original for the full detail.